SCHEMBL21055656

SCHEMBL21055656

CC(C)(C)OC(=O)n1ccc2cccc(N)c21

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACLY P53396 1/20 0.47
HSP90AA1 P07900 1/20 0.43
HSP90AB1 P08238 1/20 0.43
BUB1 O43683 1/20 0.39
BCHE P06276 1/20 0.39
NR1H2 P55055 3/20 0.38
PIK3CA P42336 3/20 0.37
PIK3CD O00329 2/20 0.37
ABL1 P00519 2/20 0.37
EGFR P00533 2/20 0.37
HCK P08631 2/20 0.37
SRC P12931 2/20 0.37
KDR P35968 2/20 0.37
PIK3CB P42338 2/20 0.37
MTOR P42345 2/20 0.37
PIK3CG P48736 2/20 0.37
EPHB4 P54760 2/20 0.37
PRKDC P78527 2/20 0.37
PI4KB Q9UBF8 2/20 0.37
TNK2 Q07912 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30711258 0.84 ACLY (0.47) ACLYHSP90AA1HSP90AB1BUB1BCHE
SCHEMBL1349273 0.84 ACLY (0.47) ACLYHSP90AA1HSP90AB1BUB1BCHE
SCHEMBL16339898 0.82 ACLY (0.54) ACLYHSP90AA1HSP90AB1BUB1BCHE
SCHEMBL2877952 0.82 ACLY (0.47) ACLYHSP90AA1HSP90AB1BUB1BCHE
SCHEMBL1314041 0.82 ACLY (0.47) ACLYHSP90AA1HSP90AB1BUB1BCHE
SCHEMBL31370595 0.82 ACLY (0.44) ACLYHSP90AA1HSP90AB1BUB1BCHE
SCHEMBL25338485 0.81 BUB1 (0.41) ACLYHSP90AA1HSP90AB1BUB1BCHE
SCHEMBL638026 0.81 ACLY (0.46) ACLYHSP90AA1HSP90AB1BUB1BCHE
SCHEMBL26240527 0.81 ACLY (0.46) ACLYHSP90AA1HSP90AB1BUB1BCHE
SCHEMBL4040904 0.81 ACLY (0.46) ACLYHSP90AA1HSP90AB1BUB1BCHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250339406-A1 NSD FAMILY INHIBITORS AND METHODS OF TREATMENT THEREWITH THE REGENTS OF THE UNIVERSITY OF MICHIGAN 2025-11-06 US disclosed
US-12364688-B2 NSD family inhibitors and methods of treatment therewith THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2025-07-22 US disclosed
US-20230046569-A1 NSD FAMILY INHIBITORS AND METHODS OF TREATMENT THEREWITH THE REGENTS OF THE UNIVERSITY OF MICHIGAN 2023-02-16 US disclosed
US-20230046569-A1 NSD FAMILY INHIBITORS AND METHODS OF TREATMENT THEREWITH THE REGENTS OF THE UNIVERSITY OF MICHIGAN 2023-02-16 US disclosed
US-11324729-B2 NSD family inhibitors and methods of treatment therewith THE REGENTS OF THE UNIVERSITY OF MICHIGAN 2022-05-10 US disclosed
US-11324729-B2 NSD family inhibitors and methods of treatment therewith THE REGENTS OF THE UNIVERSITY OF MICHIGAN 2022-05-10 US disclosed
CN-112040947-A NSD family inhibitors and methods of treatment therewith 密歇根大学董事会 2020-12-04 CN disclosed
EP-3720439-A1 NSD FAMILY INHIBITORS AND METHODS OF TREATMENT THEREWITH The Regents Of The University Of Michigan (US) 2020-10-14 EP disclosed
US-20190183865-A1 NSD FAMILY INHIBITORS AND METHODS OF TREATMENT THEREWITH THE REGENTS OF THE UNIVERSITY OF MICHIGAN 2019-06-20 US disclosed
US-20190183865-A1 NSD FAMILY INHIBITORS AND METHODS OF TREATMENT THEREWITH THE REGENTS OF THE UNIVERSITY OF MICHIGAN 2019-06-20 US disclosed
WO-2019113469-A1 NSD FAMILY INHIBITORS AND METHODS OF TREATMENT THEREWITH THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2019-06-13 WO disclosed
WO-2019113469-A1 NSD FAMILY INHIBITORS AND METHODS OF TREATMENT THEREWITH THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2019-06-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12364688-B2 NSD family inhibitors and methods of treatment therewith NSD3, NSD2, NSD1 ACLY 3320/4885HSP90AA1 1840/4885HSP90AB1 1288/4885
US-20230046569-A1 NSD FAMILY INHIBITORS AND METHODS OF TREATMENT THEREWITH NSD3, NSD2, NSD1 ACLY 3320/4885HSP90AA1 1840/4885HSP90AB1 1288/4885
US-20250339406-A1 NSD FAMILY INHIBITORS AND METHODS OF TREATMENT THEREWITH NSD3, NSD2, NSD1 ACLY 3320/4885HSP90AA1 1840/4885HSP90AB1 1288/4885
US-11324729-B2 NSD family inhibitors and methods of treatment therewith NSD3, NSD2, NSD1 ACLY 3320/4885HSP90AA1 1840/4885HSP90AB1 1288/4885
US-20190183865-A1 NSD FAMILY INHIBITORS AND METHODS OF TREATMENT THEREWITH NSD3, NSD2, NSD1 ACLY 3320/4885HSP90AA1 1840/4885HSP90AB1 1288/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.